On 2025-11-06, Sutro Biopharma, Inc. (STRO) announced earnings per share of $-6.70 for the fiscal quarter ending 2025-09-30, missing the average analyst estimate of $-4.20.
The next expected annoucement date for quarterly earnings is 2026-03-12, with an average estimated earnings per share of $-10.31 for the fiscal quarter ending 2025-12-31.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-11-06 | 2025-09-30 | $-4.20 | $-6.70 |
| 2025-08-07 | 2025-06-30 | $-3.90 | $-1.40 |
| 2025-05-08 | 2025-03-31 | $-6.30 | $-9.10 |
| 2025-03-13 | 2024-12-31 | $-8.60 | $-8.90 |
| 2024-11-13 | 2024-09-30 | $-7.40 | $-5.90 |
| 2024-08-13 | 2024-06-30 | $-7.60 | $-5.90 |
| 2024-05-13 | 2024-03-31 | $-9.20 | $-9.50 |
| 2024-03-25 | 2023-12-31 | $-8.20 | $4.20 |
| 2023-11-13 | 2023-09-30 | $-7.60 | $-8.10 |
| 2023-08-10 | 2023-06-30 | $-7.30 | $-6.40 |
| 2023-05-15 | 2023-03-31 | $-8.30 | $-7.60 |
| 2023-03-30 | 2022-12-31 | $-6.40 | $-6.10 |
| 2022-11-08 | 2022-09-30 | $-1.50 | $-3.70 |
| 2022-08-08 | 2022-06-30 | $-7.40 | $-5.50 |
| 2022-05-09 | 2022-03-31 | $-7.90 | $-8.40 |
| 2022-02-28 | 2021-12-31 | $-6.70 | $-8.30 |
| 2021-11-10 | 2021-09-30 | $-6.70 | $-6.70 |
| 2021-08-09 | 2021-06-30 | $-4.20 | $-1.30 |
| 2021-05-07 | 2021-03-31 | $-6.10 | $-4.30 |
| 2021-03-18 | 2020-12-31 | $-5.60 | $-14.80 |
| 2020-11-05 | 2020-09-30 | $-4.40 | $-3.30 |
| 2020-08-06 | 2020-06-30 | $-5.90 | $-6.00 |
| 2020-05-11 | 2020-03-31 | $-6.90 | $-8.40 |
| 2020-03-16 | 2019-12-31 | $-7.70 | $-6.40 |
| 2019-11-08 | 2019-09-30 | $-6.40 | $-5.60 |
| 2019-08-14 | 2019-06-30 | $-6.20 | $-6.00 |
| 2019-05-15 | 2019-03-31 | $-6.00 | $-6.20 |
| 2018-11-14 | 2018-09-30 | -- | $-212.60 |